Will preventive HIV vaccine efficacy trials be possible with female injection drug users?

Meyers, K; Metzger, D S; McLellan, A T; Navaline, H; Sheon, A R; Woody, G E

Meyers, K; Metzger, D S; McLellan, A T; Navaline, H; Sheon, A R; Woody, G E.

Affiliation

Meyers K; University of Pennsylvania/Philadelphia Veterans Medical Center, Center for Studies of Addiction, USA.

J Acquir Immune Defic Syndr Hum Retrovirol ; 10(5): 577-85, 1995 Dec 15.

Article in En | MEDLINE | ID: mdl-8548338

Subject(s)

AIDS Vaccines/administration & dosage; Clinical Trials as Topic/statistics & numerical data; HIV Infections/prevention & control; HIV-1; Substance Abuse, Intravenous/complications; Adult; Aged; Cohort Studies; Female; HIV Antibodies/analysis; HIV Infections/epidemiology; HIV Infections/immunology; HIV Seroprevalence/trends; Humans; Incidence; Male; Middle Aged; Patient Compliance; Philadelphia/epidemiology; Prevalence; Risk-Taking; Substance Abuse, Intravenous/psychology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Substance Abuse, Intravenous / Clinical Trials as Topic / HIV-1 / AIDS Vaccines Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: J Acquir Immune Defic Syndr Hum Retrovirol Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) / VIROLOGIA Year: 1995 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links